cis-Diamminedichloroplatinum(II) given in low-dose continuous infusion with concurrent radiotherapy to patients affected by inoperable lung carcinoma: a pharmacokinetic approach View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1998-02

AUTHORS

Franca Morazzoni, Carmen Canevali, Massimo Zucchetti, Sergio Caroli, Alessandro Alimonti, Francesco Petrucci, Gabriella Giudice, Enrico Masoni, Amedeo Vittorio Bedini

ABSTRACT

The pharmacokinetics of cis-diamminedichloro platinum(II) (cisplatin), given as a continuous infusion with concurrent radiotherapy to patients with locally advanced inoperable non-small-cell lung carcinoma, was investigated in 16 cases. The regimen, repeated for 6 consecutive weeks, consisted of weekly 10-Gy radiotherapy given in five fractions from Monday to Friday, and concurrent 100-h infusion of cisplatin delivered at a daily dose of 4 mg/m2 by a central venous catheter and a portable pump. Throughout the weeks of therapy the platinum levels were determined in plasma and in ultrafiltered plasma by respectively inductively coupled plasma atomic emission spectrometry and inductively coupled plasma mass spectrometry. Mean levels of platinum in plasma ([Pt]tot ) increased from the 1st to the 6th week of infusion, while mean levels of platinum in ultrafiltered plasma ([Pt]uf), 110 microg/l, showed no marked variation throughout the therapy. [Pt]uf ranged from 16% to 22% of the total Pt. Mean levels of Pt in ultrafiltered plasma were of the same order of magnitude as those found to be active in vitro as radiopotentiators. Pt decay levels were measured for 24 h at the end of the 1st and 5th weeks of infusion, allowing the calculation of the Pt half-life and the area under the decay curves. The mean value of the area under the decay curve, plotting [Pt]tot against time (AUC), in the range 0-24 h from the end of the 5th week of infusion, was about twice that from the end of the 1st week; by contrast, the mean AUC values did not vary for the [Pt]uf against time curves. The mean values of the alpha half-life of Pt in the ultrafiltered plasma were in accordance with those published in the literature; however, an unexpected very long beta half-life was found (more than 100 h). Thus it was suggested that Pt species other than free cisplatin were present in the ultrafiltered plasma; such species probably involve metal bound to low-molecular-mass proteins. Throughout the therapy, the toxic effects in all patients were negligible, and 75% of them had an objective locoregional reduction of disease. In only 2 cases was progression of disease observed within the irradiated area. On the basis of these data, it can be concluded that cisplatin at a level of 110 microg/l in the ultrafiltered plasma, in the reported scheme of continuous intravenous infusion, has an enhancing effect on radiation and avoids concentration peaks of platinum not bound to protein. More... »

PAGES

37-43

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s004320050131

DOI

http://dx.doi.org/10.1007/s004320050131

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1046233188

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9498833


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0202", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Atomic, Molecular, Nuclear, Particle and Plasma Physics", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/02", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Physical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Non-Small-Cell Lung", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cisplatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Milan", 
          "id": "https://www.grid.ac/institutes/grid.4708.b", 
          "name": [
            "Dipartimento di Scienza dei Materiali, Universit\u00e0 di Milano, Via Emanueli 15, 20126 Milano, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morazzoni", 
        "givenName": "Franca", 
        "id": "sg:person.01255100453.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255100453.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Milan", 
          "id": "https://www.grid.ac/institutes/grid.4708.b", 
          "name": [
            "Dipartimento di Scienza dei Materiali, Universit\u00e0 di Milano, Via Emanueli 15, 20126 Milano, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Canevali", 
        "givenName": "Carmen", 
        "id": "sg:person.0751665324.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751665324.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mario Negri Institute for Pharmacological Research", 
          "id": "https://www.grid.ac/institutes/grid.4527.4", 
          "name": [
            "Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, Via Eritrea 62, 20157 Milano, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zucchetti", 
        "givenName": "Massimo", 
        "id": "sg:person.0720105551.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720105551.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Superiore di Sanit\u00e0", 
          "id": "https://www.grid.ac/institutes/grid.416651.1", 
          "name": [
            "Laboratorio di Tossicologia Applicata, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161 Roma, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Caroli", 
        "givenName": "Sergio", 
        "id": "sg:person.01067474735.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067474735.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Superiore di Sanit\u00e0", 
          "id": "https://www.grid.ac/institutes/grid.416651.1", 
          "name": [
            "Laboratorio di Tossicologia Applicata, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161 Roma, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alimonti", 
        "givenName": "Alessandro", 
        "id": "sg:person.01247677103.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247677103.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Superiore di Sanit\u00e0", 
          "id": "https://www.grid.ac/institutes/grid.416651.1", 
          "name": [
            "Laboratorio di Tossicologia Applicata, Istituto Superiore di Sanit\u00e0, Viale Regina Elena 299, 00161 Roma, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Petrucci", 
        "givenName": "Francesco", 
        "id": "sg:person.01065335303.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01065335303.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.417893.0", 
          "name": [
            "Istituto Nazionale Tumori, Via Venezian 1, 20133 Milano, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Giudice", 
        "givenName": "Gabriella", 
        "id": "sg:person.0652707500.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652707500.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Milan", 
          "id": "https://www.grid.ac/institutes/grid.4708.b", 
          "name": [
            "Dipartimento di Scienza dei Materiali, Universit\u00e0 di Milano, Via Emanueli 15, 20126 Milano, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Masoni", 
        "givenName": "Enrico", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Istituto Nazionale dei Tumori", 
          "id": "https://www.grid.ac/institutes/grid.417893.0", 
          "name": [
            "Istituto Nazionale Tumori, Via Venezian 1, 20133 Milano, Italy, IT"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bedini", 
        "givenName": "Amedeo Vittorio", 
        "id": "sg:person.01035226740.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035226740.01"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1998-02", 
    "datePublishedReg": "1998-02-01", 
    "description": "The pharmacokinetics of cis-diamminedichloro platinum(II) (cisplatin), given as a continuous infusion with concurrent radiotherapy to patients with locally advanced inoperable non-small-cell lung carcinoma, was investigated in 16 cases. The regimen, repeated for 6 consecutive weeks, consisted of weekly 10-Gy radiotherapy given in five fractions from Monday to Friday, and concurrent 100-h infusion of cisplatin delivered at a daily dose of 4 mg/m2 by a central venous catheter and a portable pump. Throughout the weeks of therapy the platinum levels were determined in plasma and in ultrafiltered plasma by respectively inductively coupled plasma atomic emission spectrometry and inductively coupled plasma mass spectrometry. Mean levels of platinum in plasma ([Pt]tot ) increased from the 1st to the 6th week of infusion, while mean levels of platinum in ultrafiltered plasma ([Pt]uf), 110 microg/l, showed no marked variation throughout the therapy. [Pt]uf ranged from 16% to 22% of the total Pt. Mean levels of Pt in ultrafiltered plasma were of the same order of magnitude as those found to be active in vitro as radiopotentiators. Pt decay levels were measured for 24 h at the end of the 1st and 5th weeks of infusion, allowing the calculation of the Pt half-life and the area under the decay curves. The mean value of the area under the decay curve, plotting [Pt]tot against time (AUC), in the range 0-24 h from the end of the 5th week of infusion, was about twice that from the end of the 1st week; by contrast, the mean AUC values did not vary for the [Pt]uf against time curves. The mean values of the alpha half-life of Pt in the ultrafiltered plasma were in accordance with those published in the literature; however, an unexpected very long beta half-life was found (more than 100 h). Thus it was suggested that Pt species other than free cisplatin were present in the ultrafiltered plasma; such species probably involve metal bound to low-molecular-mass proteins. Throughout the therapy, the toxic effects in all patients were negligible, and 75% of them had an objective locoregional reduction of disease. In only 2 cases was progression of disease observed within the irradiated area. On the basis of these data, it can be concluded that cisplatin at a level of 110 microg/l in the ultrafiltered plasma, in the reported scheme of continuous intravenous infusion, has an enhancing effect on radiation and avoids concentration peaks of platinum not bound to protein.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s004320050131", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1313647", 
        "issn": [
          "0171-5216", 
          "1432-1335"
        ], 
        "name": "Journal of Cancer Research and Clinical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "124"
      }
    ], 
    "name": "cis-Diamminedichloroplatinum(II) given in low-dose continuous infusion with concurrent radiotherapy to patients affected by inoperable lung carcinoma: a pharmacokinetic approach", 
    "pagination": "37-43", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "dc3b90a570e3483c7f006a30fbc3139798e01be9da5d4ea55e88ea7571002cbb"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9498833"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7902060"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s004320050131"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1046233188"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s004320050131", 
      "https://app.dimensions.ai/details/publication/pub.1046233188"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8687_00000491.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s004320050131"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s004320050131'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s004320050131'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s004320050131'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s004320050131'


 

This table displays all metadata directly associated to this object as RDF triples.

177 TRIPLES      20 PREDICATES      40 URIs      32 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s004320050131 schema:about N0406b8f196be499bbc364fdf31b3c02b
2 N0b9e6c1c1a4d48b3bdc1fc89e0a9123a
3 N131ffb377633453e8483a4b96eef9e82
4 N25d8f28a2997438e995cb2780d994dbb
5 N4774e603190e4edeaadc308e164ab2e6
6 N53fcc627b1ac4eb6b5f2a79624f3ca28
7 N603dbc903a4e43fcbb7291a71a06963b
8 N9901b85c3c2e49d88618fef355f3ae4b
9 Na60877f40935435b833738b2ba7d3e61
10 Nfbfb0346d0834d49b9d18834f05dd9ec
11 Nff4ba5485c6a461bb175a426a1e1638c
12 anzsrc-for:02
13 anzsrc-for:0202
14 schema:author N5e25f2909112448fa132ec34f296d27c
15 schema:datePublished 1998-02
16 schema:datePublishedReg 1998-02-01
17 schema:description The pharmacokinetics of cis-diamminedichloro platinum(II) (cisplatin), given as a continuous infusion with concurrent radiotherapy to patients with locally advanced inoperable non-small-cell lung carcinoma, was investigated in 16 cases. The regimen, repeated for 6 consecutive weeks, consisted of weekly 10-Gy radiotherapy given in five fractions from Monday to Friday, and concurrent 100-h infusion of cisplatin delivered at a daily dose of 4 mg/m2 by a central venous catheter and a portable pump. Throughout the weeks of therapy the platinum levels were determined in plasma and in ultrafiltered plasma by respectively inductively coupled plasma atomic emission spectrometry and inductively coupled plasma mass spectrometry. Mean levels of platinum in plasma ([Pt]tot ) increased from the 1st to the 6th week of infusion, while mean levels of platinum in ultrafiltered plasma ([Pt]uf), 110 microg/l, showed no marked variation throughout the therapy. [Pt]uf ranged from 16% to 22% of the total Pt. Mean levels of Pt in ultrafiltered plasma were of the same order of magnitude as those found to be active in vitro as radiopotentiators. Pt decay levels were measured for 24 h at the end of the 1st and 5th weeks of infusion, allowing the calculation of the Pt half-life and the area under the decay curves. The mean value of the area under the decay curve, plotting [Pt]tot against time (AUC), in the range 0-24 h from the end of the 5th week of infusion, was about twice that from the end of the 1st week; by contrast, the mean AUC values did not vary for the [Pt]uf against time curves. The mean values of the alpha half-life of Pt in the ultrafiltered plasma were in accordance with those published in the literature; however, an unexpected very long beta half-life was found (more than 100 h). Thus it was suggested that Pt species other than free cisplatin were present in the ultrafiltered plasma; such species probably involve metal bound to low-molecular-mass proteins. Throughout the therapy, the toxic effects in all patients were negligible, and 75% of them had an objective locoregional reduction of disease. In only 2 cases was progression of disease observed within the irradiated area. On the basis of these data, it can be concluded that cisplatin at a level of 110 microg/l in the ultrafiltered plasma, in the reported scheme of continuous intravenous infusion, has an enhancing effect on radiation and avoids concentration peaks of platinum not bound to protein.
18 schema:genre research_article
19 schema:inLanguage en
20 schema:isAccessibleForFree false
21 schema:isPartOf N0a4e58828ed649feaee452f6790ef494
22 N9fb84f3a3216430daf45d2df3c679131
23 sg:journal.1313647
24 schema:name cis-Diamminedichloroplatinum(II) given in low-dose continuous infusion with concurrent radiotherapy to patients affected by inoperable lung carcinoma: a pharmacokinetic approach
25 schema:pagination 37-43
26 schema:productId N1eef8265e18a40cca371c5133f025310
27 N5e9711e0a55d4035a67b5a4b9452089e
28 N64f9608bb9474e4399f1f1c2d8e91cc9
29 Nb1e3c076c0c64f408809f7f8bfd27c27
30 Ncde79b8b8e8a4e939a4b5b22c7c96b92
31 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046233188
32 https://doi.org/10.1007/s004320050131
33 schema:sdDatePublished 2019-04-10T21:32
34 schema:sdLicense https://scigraph.springernature.com/explorer/license/
35 schema:sdPublisher Nad47d4fc808c4e5eb6d1320c83ac9274
36 schema:url http://link.springer.com/10.1007/s004320050131
37 sgo:license sg:explorer/license/
38 sgo:sdDataset articles
39 rdf:type schema:ScholarlyArticle
40 N0406b8f196be499bbc364fdf31b3c02b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
41 schema:name Combined Modality Therapy
42 rdf:type schema:DefinedTerm
43 N0a4e58828ed649feaee452f6790ef494 schema:volumeNumber 124
44 rdf:type schema:PublicationVolume
45 N0b9e6c1c1a4d48b3bdc1fc89e0a9123a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
46 schema:name Male
47 rdf:type schema:DefinedTerm
48 N131ffb377633453e8483a4b96eef9e82 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
49 schema:name Adult
50 rdf:type schema:DefinedTerm
51 N19eab100321d4e92bc8f05bd5f292863 rdf:first sg:person.0720105551.12
52 rdf:rest Nc4529cd555914ec1a62ef4b3058729c0
53 N1eef8265e18a40cca371c5133f025310 schema:name nlm_unique_id
54 schema:value 7902060
55 rdf:type schema:PropertyValue
56 N25d8f28a2997438e995cb2780d994dbb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
57 schema:name Carcinoma, Non-Small-Cell Lung
58 rdf:type schema:DefinedTerm
59 N436f276cf10b431bba819231b131888a rdf:first sg:person.01247677103.36
60 rdf:rest N9a47b89ec7314298bbee9354b5fe6a32
61 N4774e603190e4edeaadc308e164ab2e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
62 schema:name Humans
63 rdf:type schema:DefinedTerm
64 N53fcc627b1ac4eb6b5f2a79624f3ca28 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Middle Aged
66 rdf:type schema:DefinedTerm
67 N5e25f2909112448fa132ec34f296d27c rdf:first sg:person.01255100453.07
68 rdf:rest Nb2081f9557f748b284058ed0fb236164
69 N5e9711e0a55d4035a67b5a4b9452089e schema:name dimensions_id
70 schema:value pub.1046233188
71 rdf:type schema:PropertyValue
72 N603dbc903a4e43fcbb7291a71a06963b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Female
74 rdf:type schema:DefinedTerm
75 N64f9608bb9474e4399f1f1c2d8e91cc9 schema:name readcube_id
76 schema:value dc3b90a570e3483c7f006a30fbc3139798e01be9da5d4ea55e88ea7571002cbb
77 rdf:type schema:PropertyValue
78 N6b43f7dd2b504961bdf7585cb68a023a rdf:first sg:person.01035226740.01
79 rdf:rest rdf:nil
80 N74b65c6076ac4559a91c5f4dad12184b schema:affiliation https://www.grid.ac/institutes/grid.4708.b
81 schema:familyName Masoni
82 schema:givenName Enrico
83 rdf:type schema:Person
84 N9901b85c3c2e49d88618fef355f3ae4b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Cisplatin
86 rdf:type schema:DefinedTerm
87 N9a47b89ec7314298bbee9354b5fe6a32 rdf:first sg:person.01065335303.03
88 rdf:rest Nab8b36d9a60b4661b4c52a3b6753a769
89 N9fb84f3a3216430daf45d2df3c679131 schema:issueNumber 1
90 rdf:type schema:PublicationIssue
91 Na60877f40935435b833738b2ba7d3e61 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Antineoplastic Agents
93 rdf:type schema:DefinedTerm
94 Nab8b36d9a60b4661b4c52a3b6753a769 rdf:first sg:person.0652707500.73
95 rdf:rest Nfcdaa03aaa594d7d804b8590a8f9d2a2
96 Nad47d4fc808c4e5eb6d1320c83ac9274 schema:name Springer Nature - SN SciGraph project
97 rdf:type schema:Organization
98 Nb1e3c076c0c64f408809f7f8bfd27c27 schema:name pubmed_id
99 schema:value 9498833
100 rdf:type schema:PropertyValue
101 Nb2081f9557f748b284058ed0fb236164 rdf:first sg:person.0751665324.55
102 rdf:rest N19eab100321d4e92bc8f05bd5f292863
103 Nc4529cd555914ec1a62ef4b3058729c0 rdf:first sg:person.01067474735.12
104 rdf:rest N436f276cf10b431bba819231b131888a
105 Ncde79b8b8e8a4e939a4b5b22c7c96b92 schema:name doi
106 schema:value 10.1007/s004320050131
107 rdf:type schema:PropertyValue
108 Nfbfb0346d0834d49b9d18834f05dd9ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Aged
110 rdf:type schema:DefinedTerm
111 Nfcdaa03aaa594d7d804b8590a8f9d2a2 rdf:first N74b65c6076ac4559a91c5f4dad12184b
112 rdf:rest N6b43f7dd2b504961bdf7585cb68a023a
113 Nff4ba5485c6a461bb175a426a1e1638c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Lung Neoplasms
115 rdf:type schema:DefinedTerm
116 anzsrc-for:02 schema:inDefinedTermSet anzsrc-for:
117 schema:name Physical Sciences
118 rdf:type schema:DefinedTerm
119 anzsrc-for:0202 schema:inDefinedTermSet anzsrc-for:
120 schema:name Atomic, Molecular, Nuclear, Particle and Plasma Physics
121 rdf:type schema:DefinedTerm
122 sg:journal.1313647 schema:issn 0171-5216
123 1432-1335
124 schema:name Journal of Cancer Research and Clinical Oncology
125 rdf:type schema:Periodical
126 sg:person.01035226740.01 schema:affiliation https://www.grid.ac/institutes/grid.417893.0
127 schema:familyName Bedini
128 schema:givenName Amedeo Vittorio
129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035226740.01
130 rdf:type schema:Person
131 sg:person.01065335303.03 schema:affiliation https://www.grid.ac/institutes/grid.416651.1
132 schema:familyName Petrucci
133 schema:givenName Francesco
134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01065335303.03
135 rdf:type schema:Person
136 sg:person.01067474735.12 schema:affiliation https://www.grid.ac/institutes/grid.416651.1
137 schema:familyName Caroli
138 schema:givenName Sergio
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067474735.12
140 rdf:type schema:Person
141 sg:person.01247677103.36 schema:affiliation https://www.grid.ac/institutes/grid.416651.1
142 schema:familyName Alimonti
143 schema:givenName Alessandro
144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247677103.36
145 rdf:type schema:Person
146 sg:person.01255100453.07 schema:affiliation https://www.grid.ac/institutes/grid.4708.b
147 schema:familyName Morazzoni
148 schema:givenName Franca
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255100453.07
150 rdf:type schema:Person
151 sg:person.0652707500.73 schema:affiliation https://www.grid.ac/institutes/grid.417893.0
152 schema:familyName Giudice
153 schema:givenName Gabriella
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652707500.73
155 rdf:type schema:Person
156 sg:person.0720105551.12 schema:affiliation https://www.grid.ac/institutes/grid.4527.4
157 schema:familyName Zucchetti
158 schema:givenName Massimo
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720105551.12
160 rdf:type schema:Person
161 sg:person.0751665324.55 schema:affiliation https://www.grid.ac/institutes/grid.4708.b
162 schema:familyName Canevali
163 schema:givenName Carmen
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751665324.55
165 rdf:type schema:Person
166 https://www.grid.ac/institutes/grid.416651.1 schema:alternateName Istituto Superiore di Sanità
167 schema:name Laboratorio di Tossicologia Applicata, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy, IT
168 rdf:type schema:Organization
169 https://www.grid.ac/institutes/grid.417893.0 schema:alternateName Istituto Nazionale dei Tumori
170 schema:name Istituto Nazionale Tumori, Via Venezian 1, 20133 Milano, Italy, IT
171 rdf:type schema:Organization
172 https://www.grid.ac/institutes/grid.4527.4 schema:alternateName Mario Negri Institute for Pharmacological Research
173 schema:name Istituto di Ricerche Farmacologiche “Mario Negri”, Via Eritrea 62, 20157 Milano, Italy, IT
174 rdf:type schema:Organization
175 https://www.grid.ac/institutes/grid.4708.b schema:alternateName University of Milan
176 schema:name Dipartimento di Scienza dei Materiali, Università di Milano, Via Emanueli 15, 20126 Milano, Italy, IT
177 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...